MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Elanco Animal Health Inc

Închisă

SectorSănătate

10.79 4.35

Rezumat

Modificarea prețului

24h

Curent

Minim

10.16

Maxim

10.79

Indicatori cheie

By Trading Economics

Venit

-372M

-8M

Vânzări

-10M

1B

P/E

Medie Sector

15.441

63.778

EPS

0.14

Marjă de profit

-0.784

Angajați

9,000

EBITDA

-779M

8M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+48.12% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-279M

5.2B

Deschiderea anterioară

6.44

Închiderea anterioară

10.79

Sentimentul știrilor

By Acuity

7%

93%

3 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Elanco Animal Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 iun. 2024, 14:34 UTC

Principalele dinamici ale pieței

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

9 iul. 2024, 12:30 UTC

Achiziții, Fuziuni, Preluări

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 iul. 2024, 12:29 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 iul. 2024, 12:28 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 iul. 2024, 12:28 UTC

Achiziții, Fuziuni, Preluări

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

2 mai 2024, 17:43 UTC

Câștiguri

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 mai 2024, 13:06 UTC

Câștiguri

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Comparație

Modificare preț

Elanco Animal Health Inc Așteptări

Obiectiv de preț

By TipRanks

48.12% sus

Prognoză pe 12 luni

Medie 15.33 USD  48.12%

Maxim 20 USD

Minim 12 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruElanco Animal Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

7

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

10.53 / 10.81Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

3 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.